Supplements
GlucoDown Posts YOY Sales Surge at Two Major Drug Store Chains
Glucose Health, Inc. says accelerating GlucoDown velocity at two top national drug store chains is driving measurable y…
Supplements 18 stories
Supplements
ADC Drug Conjugate Market Hits $42.55B Forecast by 2035
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
Supplements
Betterbrand Targets Wildfire Smoke Exposure With Respiratory Supplement
Wildfire particulate exposure is emerging as a functional-foods category trigger, with brands eyeing lung-support and a…
Supplements
Neuroplasticity Pioneer Merzenich Wins Merkin Prize for Cochlear Work
Merzenich's neuroplasticity framework is foundational to the fast-growing cognitive supplement and digital therapeutics…
Supplements
World Blood Donor Day: Industry Backs Donation Awareness Push
The coalition push highlights growing intersections between blood health, iron status nutrition, and functional supplem…
Supplements
Mitapivat Phase 3 Data Highlights Anti-Hemolytic Mechanism in SCD
Pyruvate kinase activation as a therapeutic mechanism draws renewed attention as clinical-stage data surfaces at a majo…
Supplements
Morning Kick Blends Probiotics, Collagen & Adaptogens in One RTM Scoop
Multi-functional formats are reshaping the supplement beverage aisle as operators seek all-in-one finished formulations…
Supplements
Roxadustat Phase 3 Data Flags Anemia Pathway for Nutraceutical Formulators
As pharma advances HIF-PHI anemia mechanisms, functional-food and supplement brands targeting iron bioavailability and …
Supplements
Sleep.ai Brings 10 Studies to SLEEP 2026 for Product Validation
The SLEEP/APSS annual meeting offers a high-visibility stage for nutraceutical and device brands seeking clinical credi…
Supplements
OraSure FDA Clearance Expands At-Home STI Testing Access
The clearance signals continued regulatory momentum for consumer-directed diagnostics, a category intersecting with pre…
Supplements
Medicenna Expands U.S. Patent Portfolio Across IL-2, IL-4 & IL-13 Platforms
Portfolio now exceeds 100 active granted patents and applications globally, reinforcing IP barriers in the competitive …
Supplements
Tectonic Therapeutic Completes Enrollment in TX45 Phase 2 Trial
The GPCR-targeting therapeutic protein enters mid-stage evaluation in a severe cardiopulmonary subpopulation — but this…